Aprea Therapeutics
APRE
#10423
Rank
C$8.11 M
Marketcap
C$1.29
Share price
-9.93%
Change (1 day)
-74.59%
Change (1 year)

Revenue for Aprea Therapeutics (APRE)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aprea Therapeutics from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Magellan Health
MGLN
C$6.68 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
C$2.50 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
C$3.32 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA